KAM
SYRS

Kazazian Asset Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Kazazian Asset Management’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,327
Closed -$158K – 89
2018
Q3 		$158K Buy
+1,327
New +$158K 0.15% 83